CSP | CSP–RYCT | TAU | RYCT | ||
---|---|---|---|---|---|
(N=48) | (N=97) | (N=47) | (N=97) | ||
Characteristic/measure | Level | n (%) | n (%) | n (%) | n (%) |
Gender | Female | 27 (56) | 49 (51) | 29 (62) | 48 (49) |
Ethnicity | White British | 46 (96) | 81 (84) | 37 (79) | 89 (92) |
Marital status | Married/cohabiting/civil | 34 (71) | 68 (70) | 29 (62) | 65 (67) |
Living situation | Living alone | 6 (13) | 11 (11) | 8 (17) | 20 (21) |
Cohabiting with partner | 35 (73) | 65 (67) | 29 (62) | 65 (67) | |
Living with others | 7 (15) | 21 (22) | 7 (15) | 10 (10) | |
Highest level of education | School leaver (aged 14–16) | 36 (75) | 72 (74) | 33 (70) | 75 (77) |
Further/higher education | 10 (21) | 22 (23) | 11 (23) | 18 (19) | |
Missing | 2 (4.2) | 3 (3.1) | 3 (6.4) | 4 (4.1) | |
CDR | 0.5–1 | 26 (57) | 57 (60) | 32 (73) | 61 (73) |
2–3 | 20 (43) | 38 (40) | 12 (27) | 23 (27) | |
Missing | 2 | 2 | 3 | 13 | |
Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | ||
Age (years) | 79.8 (8.18) | 79.3 (7.54) | 79.5 (7.32) | 79.8 (8.36) | |
Months since diagnosis | 29.6 (20.6) | 30.9 (25.5) | 29.8 (26.1) | 33.2 (30.0) | |
MMSE | Total* | 16.3 (6.37) | 17.5 (6.35) | 19.7 (5.37) | 16.3 (7.03) |
QoL-AD | Self-report* | 37.1 (4.75) | 35.6 (5.82) | 37.6 (5.94) | 36.7 (5.50) |
Proxy* | 30.9 (6.01) | 30.0 (5.89) | 32.2 (6.81) | 30.7 (5.35) | |
DEMQOL | Self-report* | 93.4 (12.4) | 90.6 (13.4) | 92.4 (11.2) | 92.1 (12.3) |
Proxy* | 89.3 (15.6) | 94.4 (14.1) | 93.5 (15.8) | 93.8 (13.3) | |
EQ-5D | Utility value* | 0.693 (0.312) | 0.677 (0.301) | 0.763 (0.312) | 0.666 (0.316) |
Self-rated general health* | 76.2 (18.1) | 70.4 (19.4) | 76.42 (16.0) | 69.60 (21.2) | |
HADS | Total | 8.49 (6.27) | 10.6 (6.32) | 9.00 (6.28) | 9.89 (6.27) |
ADCS-ADL | Total* | 42.0 (16.4) | 41.2 (18.1) | 44.3 (19.4) | 42.2 (17.6) |
NPI | Total | 23.4 (17.7) | 21.4 (16.9) | 22.5 (17.2) | 28.1 (22.3) |
Quality of relationship | QCPR total* | 58.5 (6.11) | 57.4 (6.56) | 58.6 (5.96) | 58.4 (6.41) |
*Higher scores are better.
ADCS-ADL, Alzheimer's Disease Cooperative Study—Activities of Daily Living; CDR, clinical dementia rating; DEMQOL, quality of life for people with dementia; EQ-5D, EuroQol 5 dimensions; HADS, Hospital Anxiety and Depression Scale; MMSE, mini-mental state examination; NPI, neuropsychiatric inventory; QCPR, Quality of Caregiver–Patient Relationship; QoL-AD, Quality of Life in Alzheimer's Disease Scale.